As chairman of the Pricing, Reimbursement, and Access Steering Committee for Lilly USA and as the relevant profit and loss business unit leader for the biomedicines business unit for the United States, I approved pricing recommendations for this medicine.
Wyden cites Azar's role in pricing strategies for a specific drug during his tenure at Lilly USA.
Share
More from Ron Wyden
Flock’s AI surveillance cameras have sparked a nationwide backlash against unnecessary government intrusion into Americans’ lives.
This interpretation is wildly inconsistent with the longstanding treatment of other provisions that use identical or near-identical language.
The White House should make MITRE’s findings public as soon as possible.
As Congress debates solutions to protect our privacy and civil liberties, the MITRE report could provide important information about how these cameras and other surveillance programs are already impacting Americans’ rights.
Other voices in this conversation
